BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1592 related articles for article (PubMed ID: 16457953)

  • 1. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats.
    Givalois L; Naert G; Rage F; Ixart G; Arancibia S; Tapia-Arancibia L
    Mol Cell Neurosci; 2004 Nov; 27(3):280-95. PubMed ID: 15519243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats.
    Seale JV; Wood SA; Atkinson HC; Harbuz MS; Lightman SL
    J Neuroendocrinol; 2004 Dec; 16(12):989-98. PubMed ID: 15667454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
    Greisen MH; Bolwig TG; Wörtwein G
    Behav Brain Res; 2005 Jun; 161(2):204-12. PubMed ID: 15922046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD; Jessop DS; Fulford AJ
    Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal glucocorticoids blunt the functioning of the hypothalamic-pituitary-adrenal axis of neonates and disturb some behaviors in juveniles.
    Burlet G; Fernette B; Blanchard S; Angel E; Tankosic P; Maccari S; Burlet A
    Neuroscience; 2005; 133(1):221-30. PubMed ID: 15893645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
    J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T; Subburaju S; Wynn PC; Aguilera G
    J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
    Rotllant D; Armario A
    Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain.
    Bomholt SF; Mikkelsen JD; Blackburn-Munro G
    Brain Res; 2005 May; 1044(2):216-26. PubMed ID: 15885220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress.
    Naert G; Ixart G; Maurice T; Tapia-Arancibia L; Givalois L
    Mol Cell Neurosci; 2011 Jan; 46(1):55-66. PubMed ID: 20708081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term voluntary exercise and the mouse hypothalamic-pituitary-adrenocortical axis: impact of concurrent treatment with the antidepressant drug tianeptine.
    Droste SK; Schweizer MC; Ulbricht S; Reul JM
    J Neuroendocrinol; 2006 Dec; 18(12):915-25. PubMed ID: 17076767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats.
    Naert G; Maurice T; Tapia-Arancibia L; Givalois L
    Psychoneuroendocrinology; 2007; 32(8-10):1062-78. PubMed ID: 17928160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
    J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.